Sensitivity analyses for effect modifiers not observed in the target population when generalizing treatment effects from a randomized controlled trial: Assumptions, models, effect scales, data scenarios, and implementation details

From Trial to Target Populations — Calibrating Real-World Data

(2017) Mehdi Najafzadeh et al.   NEW ENGLAND JOURNAL OF MEDICINE

Causal Impact: Epidemiological Approaches for a Public Health of Consequence

(2016) Daniel Westreich et al.   AMERICAN JOURNAL OF PUBLIC HEALTH

A framework for the analysis of heterogeneity of treatment effect in patient-centered outcomes research

(2013) Ravi Varadhan et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

The use of propensity scores and observational data to estimate randomized controlled trial generalizability bias

(2013) Taylor R. Pressler et al.   STATISTICS IN MEDICINE

Estimating treatment effect via simple cross design synthesis

(2011) Eloise E. Kaizar   STATISTICS IN MEDICINE

Generalizing Evidence From Randomized Clinical Trials to Target Populations: The ACTG 320 Trial

(2010) S. R. Cole et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposal

(2010) David M Kent et al.   Trials

Estimation of HIV Incidence in the United States

(2008) H. Irene Hall   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION